Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Novavax's Pre-Tax Income for the
three
months ended in Dec. 2023 was $-176.7 Mil. Novavax's Revenue for the
three
months ended in Dec. 2023 was $253.4 Mil. Therefore, Novavax's pretax margin for the quarter that ended in Dec. 2023 was -69.73%.
The historical rank and industry rank for Novavax's Pretax Margin % or its related term are showing as below:
NVAX'
s Pretax Margin % Range Over the Past 10 Years
Min: -1868.23 Med: -564.14 Max: -40.88
Current: -78.31
NVAX's Pretax Margin % is ranked better than 57.64% of 1027
companies
in the Biotechnology industry
Industry Median: -176.72
vs NVAX: -78.31
Novavax Pretax Margin % Historical Data
The historical data trend for Novavax's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Novavax's Pretax Margin %
For the Biotechnology subindustry, Novavax's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novavax's Pretax Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Novavax's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Novavax's Pretax Margin % falls into.
Novavax Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
Novavax's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novavax (NAS:NVAX) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Novavax Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Novavax's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NVAX has been successfully added to your 